SHR-2554 | m-entrepreneurship.com

Product Name :
SHR-2554

Search keywords :
KMT6

drugId :
null

Target Vo:
Histone-lysine N-methyltransferase EZH2

Target Vo Short Name :
EZH2

Moa_Name:
Histone-lysine N-methyltransferase EZH2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Jiangsu Hengrui Medicine Co Ltd

Active Company_Name :
Fudan University

Active Indication_Name:
Lymphoma, T-Cell

In Active Indication_Name:
Prostatic Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD9 Antibody
CDKN2A Antibody
GRB2 Antibody: GRB2 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 25 kDa, targeting to GRB2. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human, Rat.

Author: Betaine hydrochloride

Related Posts